Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL4904766

COc1cc(Br)ccc1N=C(c1ccccc1)c1ccccc1.N

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
HPGD P15428 1/20 0.40
CYP2C19 P33261 1/20 0.40
ALDH1A1 P00352 2/20 0.39
POLB P06746 1/20 0.39
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
LMNA P02545 2/20 0.38
TSHR P16473 1/20 0.38
TUBB4A P04350 1/20 0.38
TUBB P07437 1/20 0.38
TUBA3C P0DPH7 1/20 0.38
TUBA1B P68363 1/20 0.38
TUBA4A P68366 1/20 0.38
TUBB4B P68371 1/20 0.38
TUBB3 Q13509 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4667993 0.98 CYP1A2 (0.41) CYP1A2CYP2D6HPGDCYP2C19ALDH1A1
SCHEMBL30416262 0.79 NOS3 (0.50) HPGDALDH1A1POLBNPC1RAB9A
SCHEMBL6547372 0.79 NOS3 (0.50) HPGDALDH1A1POLBNPC1RAB9A
SCHEMBL16229861 0.78 ENPP2 (0.39) CYP1A2ALDH1A1POLBNPC1RAB9A
SCHEMBL8358341 0.78 SIGMAR1 (0.50) ALDH1A1POLBNPC1RAB9ASMN1; SMN2
SCHEMBL18323876 0.77 ALDH1A1 (0.37) CYP1A2CYP2D6HPGDCYP2C19ALDH1A1
SCHEMBL25389224 0.74 GRIN2B (0.43) HPGDALDH1A1POLBNPC1RAB9A
SCHEMBL8356086 0.74 NPC1 (0.41) HPGDALDH1A1POLBNPC1RAB9A
SCHEMBL7927948 0.72 PTGDR2 (0.39) HPGDALDH1A1POLBNPC1RAB9A
SCHEMBL16102283 0.72 ALDH1A1 (0.35) CYP1A2HPGDALDH1A1POLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269523-A1 Preparation of Aminoaryl and Aminoheteroaryl Boronic Acids and Derivatives Thereof ARCHIMICA GMBH (DE) 2008-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269523-A1 Preparation of Aminoaryl and Aminoheteroaryl Boronic Acids and Derivatives Thereof BCAT1, BCAT2, AADAT CYP1A2 787/4885CYP2D6 1012/4885HPGD 3195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.